PD98059 is an equipotent antagonist of the aryl hydrocarbon receptor and inhibitor of mitogen-activated protein kinase kinase - PubMed (original) (raw)

PD98059 is an equipotent antagonist of the aryl hydrocarbon receptor and inhibitor of mitogen-activated protein kinase kinase

J J Reiners Jr et al. Mol Pharmacol. 1998 Mar.

Abstract

PD98059 [2-(2'-amino-3'-methoxyphenyl)-oxanaphthalen-4-one] is a flavonoid and a potent inhibitor of mitogen-activated protein kinase kinase (MEK). Concentrations of PD98059 of </=20 muM were not cytotoxic to cultures of the immortalized human breast epithelial cell line MCF10A. The agent was weakly cytostatic at concentrations of >/=10 microM. In vivo exposure of cultures to </=20 microM PD98059 for 2-22 hr did not affect overall extracellular signal-regulated kinase contents; however, exposure to PD98059 resulted in a rapid loss (>95%) of the dually phosphorylated forms of extracellular signal-regulated kinase (IC50 = 1 muM). Treatment of cultures with PD98059 of >/=1 muM either at the time of addition or up to 48 hr before the addition of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) suppressed in a concentration-dependent manner the accumulation of induced steady state CYP1A1, CYP1B1, and NQO1 mRNAs. The addition of PD98059 to rat liver cytosol just before the addition of TCDD suppressed TCDD binding (IC50 = 4 muM) and aryl hydrocarbon receptor (AHR) transformation (IC50 = 1 muM), as measured by sucrose gradient centrifugation and electrophoretic mobility shift assays. Flavone and flavanone, two closely related structural analogs of PD98059, inhibited AHR transformation by TCDD with IC50 values similar to that obtained with PD98059. However, neither analog was as potent as PD98059 in inhibiting MEK (IC50 approximately 190 muM for both). These results suggest that PD98059 is a ligand for the AHR and functions as an AHR antagonist at concentrations commonly used to inhibit MEK and signaling processes that entail MEK activation.

PubMed Disclaimer

Cited by

Unveiling the Hidden Impact: Hematoma Volumes Unravel Circuit Disruptions in Intracerebral Hemorrhage.
Wu Y, Deng Q, Wei R, Chen S, Ding F, Yu H, Hu N, Hao S, Wang B. Wu Y, et al. Transl Stroke Res. 2024 May 15. doi: 10.1007/s12975-024-01257-6. Online ahead of print. Transl Stroke Res. 2024. PMID: 38748378
Flavonoids in Combination with Stem Cells for the Treatment of Neurological Disorders.
Lotfi MS, Kalalinia F. Lotfi MS, et al. Neurochem Res. 2023 Nov;48(11):3270-3282. doi: 10.1007/s11064-023-03986-w. Epub 2023 Jul 18. Neurochem Res. 2023. PMID: 37462837 Review.
Strategies for Improving Photodynamic Therapy Through Pharmacological Modulation of the Immediate Early Stress Response.
de Klerk DJ, de Keijzer MJ, Dias LM, Heemskerk J, de Haan LR, Kleijn TG, Franchi LP, Heger M; Photodynamic Therapy Study Group. de Klerk DJ, et al. Methods Mol Biol. 2022;2451:405-480. doi: 10.1007/978-1-0716-2099-1_20. Methods Mol Biol. 2022. PMID: 35505025 Review.
Ouabain Promotes Gap Junctional Intercellular Communication in Cancer Cells.
Serrano-Rubi M, Jimenez L, Martinez-Rendon J, Cereijido M, Ponce A. Serrano-Rubi M, et al. Int J Mol Sci. 2020 Dec 31;22(1):358. doi: 10.3390/ijms22010358. Int J Mol Sci. 2020. PMID: 33396341 Free PMC article.

PD98059 is an equipotent antagonist of the aryl hydrocarbon receptor and inhibitor of mitogen-activated protein kinase kinase - PubMed (original) (raw)